I am a physician who specializes in the development and interpretation of diagnostic tests on cancer tissue such as brain and gastrointestinal tumors. I work closely with colleagues from surgical oncology, clinical bioinformatics, and medical oncology to establish accurate diagnoses that enable personalized and targeted therapies for people with these tumors. I have board certifications in anatomic pathology, clinical pathology, and molecular genetic pathology.
After majoring in computer science and bioinformatics, I pursued a career in medicine with a vision to use mathematical and computational techniques to better understand, diagnose, and treat disease. My research has focused on the development and validation of new lab test methods based on DNA profiling technology and the application of machine learning techniques to large medical data sets.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jamal Benhamida discloses the following relationships and financial interests:
DocDoc Pte. Ltd. Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.